ALX Oncology Holdings (ALXO) ROE US GAAP (year values)

2021 2022 2023 2024 2025   LTM ?
ROE, % ? -23.0% -46.9% -84.8% -118.7% -391.4%   -391.4%
Changes by years, y/y, % -62pp -24pp -38pp -34pp -273pp    

ALX Oncology Holdings. ROE, %

ALX Oncology Holdings. ROE, changes, pp

ALX Oncology Holdings (ALXO) ROE US GAAP (quarter values)

2024Q4 2025Q1 2025Q2 2025Q3 2025Q4   LTM ?
ROE, % ? -118.7% -147.3% -181.0% -241.1% -391.4%   -391.4%
Changes by years, y/y, % -34pp -46pp -73pp -131pp -273pp    
Changes by quarters, q/q, % -8pp -29pp -34pp -60pp -150pp    

ALX Oncology Holdings. ROE, %

ALX Oncology Holdings. ROE, changes, pp

ALX Oncology Holdings. ROE, changes, pp